Osteocalcin‑GPRC6A: An update of its clinical and biological multi‑organic interactions (Review)
- Authors:
- Martha Cristina Diaz‑Franco
- Raul Franco‑Diaz de Leon
- Jose Rafael Villafan‑Bernal
-
Affiliations: Health Science Center, Autonomous University of Aguascalientes, Aguascalientes 20131, Mexico - Published online on: November 5, 2018 https://doi.org/10.3892/mmr.2018.9627
- Pages: 15-22
-
Copyright: © Diaz‑Franco et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Moore KL and Dalley AF: Clinically oriented anatomy. Lipp Williams Wilkins. 2013. | |
Ferron M, Hinoi E, Karsenty G and Ducy P: Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA. 105:5266–5270. 2008. View Article : Google Scholar : PubMed/NCBI | |
Villafán-Bernal JR, Sánchez-Enríquez S and Muñoz-Valle JF: Molecular modulation of osteocalcin and its relevance in diabetes (Review). Int J Mol Med. 28:283–293. 2011.PubMed/NCBI | |
Hauschka PV, Lian JB, Cole DE and Gundberg CM: Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev. 69:990–1047. 1989. View Article : Google Scholar : PubMed/NCBI | |
Hernández-Gil IFT, Gracia MAA, Pingarrón MDC and Jerez LB: Bases fisiológicas de la regeneración ósea I. Histología y fisiología del tejido óseo. Med Oral Patol Oral Cir Bucal. 11:47–51. 2006. | |
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, et al: Endocrine regulation of energy metabolism by the skeleton. Cell. 130:456–469. 2007. View Article : Google Scholar : PubMed/NCBI | |
Pi M, Wu Y and Quarles LD: GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo. J Bone Miner Res. 26:1680–1683. 2011. View Article : Google Scholar : PubMed/NCBI | |
De Toni L, De Filippis V, Tescari S, Ferigo M, Ferlin A, Scattolini V, Avogaro A, Vettor R and Foresta C: Uncarboxylated osteocalcin stimulates 25-hydroxy vitamin D production in Leydig cell line through a GPRC6a-dependent pathway. Endocrinology. 155:4266–4274. 2014. View Article : Google Scholar : PubMed/NCBI | |
Clemmensen C, Smajilovic S, Wellendorph P and Bräuner-Osborne H: The GPCR class C, group 6, subtype A (GPRC6A) receptor: Fom cloning to physiological function. Br J Pharmacol. 171:1129–1141. 2014. View Article : Google Scholar : PubMed/NCBI | |
Jørgensen S, Have CT, Underwood CR, Johansen LD, Wellendorph P, Gjesing AP, Jørgensen CV, Quan S, Rui G, Inoue A, et al: Genetic variations in the human G protein-coupled receptor class C, group 6, member A (GPRC6A) control cell surface expression and function. J Biol Chem. 292:1524–1534. 2017. View Article : Google Scholar : PubMed/NCBI | |
Arnold KA, Eichelbaum M and Burk O: Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. Nucl Recept. 2:12004. View Article : Google Scholar : PubMed/NCBI | |
Wellendorph P and Bräuner-Osborne H: Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene. 335:37–46. 2004. View Article : Google Scholar : PubMed/NCBI | |
Ozaki KI, Awazu M, Tamiya M, Iwasaki Y, Harada A, Kugisaki S, Tanimura S and Kohno M: Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes. Am J Physiol Endocrinol Metab. 310:E643–E651. 2016. View Article : Google Scholar : PubMed/NCBI | |
Mera P, Laue K, Wei J, Berger JM and Karsenty G: Osteocalcin is necessary and sufficient to maintain muscle mass in older mice. Mol Metab. 5:1042–1047. 2016. View Article : Google Scholar : PubMed/NCBI | |
Du J, Zhang M, Lu J, Zhang X, Xiong Q, Xu Y, Bao Y and Jia W: Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK. Endocrine. 53:701–709. 2016. View Article : Google Scholar : PubMed/NCBI | |
Pi M, Kapoor K, Ye R, Nishimoto SK, Smith JC, Baudry J and Quarles LD: Evidence for osteocalcin binding and activation of GPRC6A in β-cells. Endocrinology. 157:1866–1880. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wei J, Hanna T, Suda N, Karsenty G and Ducy P: Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a. Diabetes. 63:1021–1031. 2014. View Article : Google Scholar : PubMed/NCBI | |
Otani T, Mizokami A, Hayashi Y, Gao J, Mori Y, Nakamura S, Takeuchi H and Hirata M: Signaling pathway for adiponectin expression in adipocytes by osteocalcin. Cell Signal. 27:532–544. 2015. View Article : Google Scholar : PubMed/NCBI | |
Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, et al: Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab. 23:1078–1092. 2016. View Article : Google Scholar : PubMed/NCBI | |
Ferron M, McKee MD, Levine RL, Ducy P and Karsenty G: Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 50:568–575. 2012. View Article : Google Scholar : PubMed/NCBI | |
Karsenty G and Oury F: Regulation of male fertility by the bone-derived hormone osteocalcin. Mol Cell Endocrinol. 382:521–526. 2014. View Article : Google Scholar : PubMed/NCBI | |
Le B, Chen H, Zirkin B and Burnett A: New targets for increasing endogenous testosterone production: Clinical implications and review of the literature. Andrology. 2:484–490. 2014. View Article : Google Scholar : PubMed/NCBI | |
Oury F, Ferron M, Huizhen W, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, et al: Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest. 123:2421–2433. 2013. View Article : Google Scholar : PubMed/NCBI | |
Smith LB and Saunders PT: The skeleton: The new controller of male fertility? Cell. 144:642–643. 2011. View Article : Google Scholar : PubMed/NCBI | |
Mizokami A, Yasutake Y, Higashi S, Kawakubo-Yasukochi T, Chishaki S, Takahashi I, Takeuchi H and Hirata M: Oral administration of osteocalcin improves glucose utilization by stimulating glucagon-like peptide-1 secretion. Bone. 69:68–79. 2014. View Article : Google Scholar : PubMed/NCBI | |
Mizokami A, Yasutake Y, Gao J, Matsuda M, Takahashi I, Takeuchi H and Hirata M: Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice. PLoS One. 8:e573752013. View Article : Google Scholar : PubMed/NCBI | |
Zhao C, Liang J, Yang Y, Yu M and Qu X: The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms. Front Endocrinol (Lausanne). 8:982017. View Article : Google Scholar : PubMed/NCBI | |
Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, et al: Increased bone formation in osteocalcin-deficient mice. Nature. 382:448–452. 1996. View Article : Google Scholar : PubMed/NCBI | |
Li Y and Li K: Osteocalcin induces growth hormone/insulin-like growth factor-1 system by promoting testosterone synthesis in male mice. Horm Metab Res. 46:768–773. 2014. View Article : Google Scholar : PubMed/NCBI | |
Khrimian L, Obri A and Karsenty G: Modulation of cognition and anxiety-like behavior by bone remodeling. Mol Metab. 6:1610–1615. 2017. View Article : Google Scholar : PubMed/NCBI | |
Khrimian L, Obri A, Ramos-Brossier M, Rousseaud A, Moriceau S, Nicot AS, Mera P, Kosmidis S, Karnavas T, Saudou F, et al: Gpr158 mediates osteocalcin's regulation of cognition. J Exp Med. 214:2859–2873. 2017. View Article : Google Scholar : PubMed/NCBI | |
Obri A, Khrimian L, Karsenty G and Oury F: Osteocalcin in the brain: From embryonic development to age-related decline in cognition. Nat Rev Endocrinol. 14:174–182. 2018. View Article : Google Scholar : PubMed/NCBI | |
Di Nisio A, Rocca MS, Fadini GP, De Toni L, Marcuzzo G, Marescotti MC, Sanna M, Plebani M, Vettor R, Avogaro A and Foresta C: The rs2274911 polymorphism in GPRC6A gene is associated with insulin resistance in normal weight and obese subjects. Clin Endocrinol (Oxf). 86:185–191. 2017. View Article : Google Scholar : PubMed/NCBI | |
Pietschmann P and Schernthaner G: The effect of pirenzepine on growth hormone and blood glucose levels in type I diabetes mellitus. A controlled study in patients on basal bolus insulin treatment. Acta Endocrinol (Copenh). 117:315–319. 1988. View Article : Google Scholar : PubMed/NCBI | |
Rosato MT, Schneider SH and Shapses SA: Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif Tissue Int. 63:107–111. 1998. View Article : Google Scholar : PubMed/NCBI | |
Akin O, Göl K, Aktürk M and Erkaya S: Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol. 17:19–29. 2003. View Article : Google Scholar : PubMed/NCBI | |
Achemlal L, Tellal S, Rkiouak F, Nouijai A, Bezza A, Derouiche el M, Ghafir D and El Maghraoui A: Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol. 24:493–496. 2005. View Article : Google Scholar : PubMed/NCBI | |
Sanchez-Enriquez S, Ballesteros-Gonzalez IT, Villafán-Bernal JR, Pascoe-Gonzalez S, Rivera-Leon EA, Bastidas-Ramirez BE, Rivas-Carrillo JD, Alcala-Zermeno JL, Armendariz-Borunda J, Llamas-Covarrubias IM and Zepeda-Moreno A: Serum levels of undercarboxylated osteocalcin are related to cardiovascular risk factors in patients with type 2 diabetes mellitus and healthy subjects. World J Diabetes. 8:11–17. 2017. View Article : Google Scholar : PubMed/NCBI | |
Díaz-López A, Bulló M, Juanola-Falgarona M, Martínez-González MA, Estruch R, Covas MI, Arós F and Salas-Salvadó J: Reduced serum concentrations of carboxylated and undercarboxylated osteocalcin are associated with risk of developing type 2 diabetes mellitus in a high cardiovascular risk population: A nested case-control study. J Clin Endocrinol Metab. 98:4524–4531. 2013. View Article : Google Scholar : PubMed/NCBI | |
Razny U, Fedak D, Kiec-Wilk B, Goralska J, Gruca A, Zdzienicka A, Kiec-Klimczak M, Solnica B, Hubalewska-Dydejczyk A and Malczewska-Malec M: Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes. Diabetes Metab Res Rev. 33:2017. View Article : Google Scholar : PubMed/NCBI | |
Liu C, Wo J, Zhao Q, Wang Y, Wang B and Zhao W: Association between serum total osteocalcin level and type 2 diabetes mellitus: A systematic review and meta-analysis. Horm Metab Res. 47:813–819. 2015. View Article : Google Scholar : PubMed/NCBI | |
Kunutsor SK, Apekey TA and Laukkanen JA: Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: Systematic review and meta-analysis of observational evidence. Eur J Epidemiol. 30:599–614. 2015. View Article : Google Scholar : PubMed/NCBI | |
Luo Y, Ma X, Hao Y, Xiong Q, Xu Y, Pan X, Bao Y and Jia W: Relationship between serum osteocalcin level and carotid intima-media thickness in a metabolically healthy Chinese population. Cardiovasc Diabetol. 14:822015. View Article : Google Scholar : PubMed/NCBI | |
Sheng L, Cao W, Cha B, Chen Z, Wang F and Liu J: Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 12:222013. View Article : Google Scholar : PubMed/NCBI | |
Pirilä S, Taskinen M, Turanlahti M, Kajosaari M, Mäkitie O, Saarinen-Pihkala UM and Viljakainen H: Bone health and risk factors of cardiovascular disease-a cross-sectional study in healthy young adults. PLoS One. 9:e1080402014. View Article : Google Scholar : PubMed/NCBI | |
Maser RE, Lenhard MJ, Sneider MB and Pohlig RT: Osteoprotegerin is a better serum biomarker of coronary artery calcification than osteocalcin in type 2 diabetes. Endocr Pract. 21:14–22. 2015. View Article : Google Scholar : PubMed/NCBI | |
Giudici KV PhD, Fisberg RM, Marchioni DML, Peters BSE and Martini LA: Crosstalk between bone and fat tissue: Associations between vitamin D, osteocalcin, adipokines, and markers of glucose metabolism among adolescents. J Am Coll Nutr. 36:273–280. 2017. View Article : Google Scholar : PubMed/NCBI | |
Tan A, Gao Y, Yang X, Zhang H, Qin X, Mo L, Peng T, Xia N and Mo Z: Low serum osteocalcin level is a potential marker for metabolic syndrome: Results from a Chinese male population survey. Metabolism. 60:1186–1192. 2011. View Article : Google Scholar : PubMed/NCBI | |
Wang JW, Tang QY, Ruan HJ and Cai W: Relation between serum osteocalcin levels and body composition in obese children. J Pediatr Gastroenterol Nutr. 58:729–732. 2014.PubMed/NCBI | |
Alfadda AA, Masood A, Shaik SA, Dekhil H and Goran M: Association between osteocalcin, metabolic syndrome, and cardiovascular risk factors: Role of total and undercarboxylated osteocalcin in patients with type 2 diabetes. Int J Endocrinol. 2013:1975192013. View Article : Google Scholar : PubMed/NCBI | |
Magni P, Macchi C, Sirtori CR and Corsi Romanelli MM: Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases. Clin Chem Lab Med. 54:1579–1587. 2016. View Article : Google Scholar : PubMed/NCBI | |
Ma H, Lin H, Hu Y, Li X, He W, Jin X, Gao J, Zhao N and Gao X: Serum levels of osteocalcin in relation to glucose metabolism and carotid atherosclerosis in Chinese middle-aged and elderly male adults: The Shanghai Changfeng Study. Eur J Intern Med. 25:259–264. 2014. View Article : Google Scholar : PubMed/NCBI | |
Yang R, Ma X, Dou J, Wang F, Luo Y, Li D, Zhu J, Bao Y and Jia W: Relationship between serum osteocalcin levels and carotid intima-media thickness in Chinese postmenopausal women. Menopause. 20:1194–1199. 2013. View Article : Google Scholar : PubMed/NCBI | |
Reyes G, arcía R, Rozas Moreno P and Muñoz-Torres M: Osteocalcin and atherosclerosis: A complex relationship. Diabetes Res Clin Pract. 92:405–406. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S and Sugimoto T: Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 94:45–49. 2009. View Article : Google Scholar : PubMed/NCBI | |
Bradburn S, McPhee JS, Bagley L, Sipila S, Stenroth L, Narici MV, Pääsuke M, Gapeyeva H, Osborne G, Sassano L, et al: Association between osteocalcin and cognitive performance in healthy older adults. Age Ageing. 45:844–849. 2016. View Article : Google Scholar : PubMed/NCBI | |
Amin S, El Amrousy D, Elrifaey S, Gamal R and Hodeib H: Serum osteocalcin levels in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 66:117–121. 2018. View Article : Google Scholar : PubMed/NCBI | |
Abd-Allah Ebrahim HT and El-Behery EG: Osteocalcin: A new biomarker for non alcoholic fatty liver disease (NAFLD) in children and adolescents. Clin Med Biochem. 3:1332017. | |
Zhang Q, Riddle RC and Clemens TL: Bone and the regulation of global energy balance. J Intern Med. 277:681–689. 2015. View Article : Google Scholar : PubMed/NCBI | |
Iki M, Tamaki J, Fujita Y, et al: Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int. 23:761–770. 2012. View Article : Google Scholar : PubMed/NCBI | |
Villafán-Bernal JR, Llamas-Covarrubias MA, Muñoz-Valle JF, et al: A cut-point value of uncarboxylated to carboxylated index is associated with glycemic status markers in type 2 diabetes. J Investig Med. 62:33–36. 2014. View Article : Google Scholar : PubMed/NCBI |